CN110607313A - Recombinant strain for high yield of L-lysine and construction method and application thereof - Google Patents

Recombinant strain for high yield of L-lysine and construction method and application thereof Download PDF

Info

Publication number
CN110607313A
CN110607313A CN201910926308.1A CN201910926308A CN110607313A CN 110607313 A CN110607313 A CN 110607313A CN 201910926308 A CN201910926308 A CN 201910926308A CN 110607313 A CN110607313 A CN 110607313A
Authority
CN
China
Prior art keywords
seq
polynucleotide sequence
recombinant
strain
pobb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910926308.1A
Other languages
Chinese (zh)
Other versions
CN110607313B (en
Inventor
孟刚
马风勇
周晓群
贾慧萍
苏厚波
杨立鹏
高晓航
田斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NINGXIA EPPEN BIOTECH Co.,Ltd.
Original Assignee
Inner Mongolia Iray Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inner Mongolia Iray Biological Technology Co Ltd filed Critical Inner Mongolia Iray Biological Technology Co Ltd
Priority to CN201910926308.1A priority Critical patent/CN110607313B/en
Publication of CN110607313A publication Critical patent/CN110607313A/en
Application granted granted Critical
Publication of CN110607313B publication Critical patent/CN110607313B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a recombinant strain for producing L-lysine with high yield, a construction method and application thereof, which comprise a modified pobB gene coding polynucleotide sequence, a polynucleotide sequence shown as SEQ ID NO.2, recombinant protein coded by the polynucleotide sequence, and the recombinant strain containing the polynucleotide sequence, the construction method of the recombinant strain and the application thereof in producing L-lysine by fermentation. The recombinant strain of the invention obtains the recombinant strain with modified pobB gene coding region by carrying out point mutation on the nucleotide sequence of the pobB gene open reading frame coding region in wild corynebacterium glutamicum, and realizes the improvement of the yield of L-lysine compared with the wild strain.

Description

Recombinant strain for high yield of L-lysine and construction method and application thereof
Technical Field
The invention belongs to the technical field of genetic engineering and microorganisms, and particularly relates to a recombinant strain for high yield of L-lysine, a construction method and application thereof.
Background
L-lysine is one of the eight major amino acids essential for human and animal life activities. L-lysine has various physiological functions, such as regulating metabolic balance, promoting human development, promoting the absorption of cereal protein and other amino acids by the body, enhancing the immune function and the like, and is widely applied to various aspects such as food additives, animal feeds, drug synthesis and the like.
The production method of L-lysine mainly comprises a protein hydrolysis method, a microbial fermentation method and the like. Among them, the microbial fermentation method has been called the most commonly used method for industrially producing L-lysine because of the advantages of easy control of the production process, high productivity, etc. The microbial fermentation method is to realize the accumulation of L-lysine in the fermentation liquid by fermenting the microbes capable of metabolizing and synthesizing lysine and utilizing the microbial metabolism.
Microorganisms for producing L-lysine include various species such as coryneform bacteria, Bacillus, Escherichia, and the like. However, wild-type strains have poor L-lysine productivity and a large number of metabolic byproducts, and it is difficult to prepare L-lysine with high purity and high yield. Therefore, it is generally desired to obtain a strain having a high L-lysine yield. At present, methods for obtaining high-yield strains mainly comprise mutation screening breeding or genetic engineering breeding. Mutation breeding means that a strain is induced to generate nonspecific gene site mutation by ultraviolet irradiation or stimulation of other external conditions, and then a high-yield strain is obtained by screening. Genetic engineering is the optimization of selected strains by means of well-defined genetic engineering, for example by introducing beneficial enzyme genes with increased enzyme activity by increased copy or site-directed mutagenesis, or by knocking out undesired genes to abolish enzyme activity/expression. Corynebacterium glutamicum (Corynebacterium glutamicum) is the most commonly used L-lysine-producing strain, and the Diaminopimelic Acid (DAP) pathway is the major L-lysine biosynthetic pathway. There are four different variations of the DAP pathway for the synthesis of meso-DAP, including: a dehydrogenase pathway, a succinylase pathway, an acetylase pathway and a transaminase pathway. The Corynebacterium glutamicum has both a dehydrogenase pathway and a succinylase pathway. The dehydrogenase pathway can produce meso-DAP (i.e., diaminopimelate dehydrogenase DDH) and thus L-lysine, through only one enzymatic reaction. In order to increase the accumulation of L-lysine in the biosynthetic pathway of C.glutamicum, it is a very important strategy to increase the amount of NADPH in its metabolic pathway or to reduce the NADPH requirement in the biosynthetic pathway of L-lysine. However, an excessive intracellular amount of NADPH inhibits the utilization of saccharides by bacterial cells, and affects the growth of bacterial cells and the accumulation of L-lysine. Therefore, it is still of great interest to construct high producing strains with L-lysine.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a recombinant strain for high yield of L-lysine and a construction method and application thereof. Specifically, the invention provides a modified pobB gene encoding polynucleotide sequence, a recombinant protein encoded by the polynucleotide sequence, a recombinant strain containing the polynucleotide sequence, a construction method of the recombinant strain and application of the recombinant strain in fermentation production of L-lysine. The recombinant strain of the invention obtains the recombinant strain with modified pobB gene coding region by carrying out point mutation on the nucleotide sequence of the pobB gene open reading frame coding region in wild corynebacterium glutamicum, and realizes the improvement of the yield of L-lysine compared with the wild strain.
The invention is realized by adopting the following technical scheme:
in a first aspect of the invention, there is provided a polynucleotide sequence comprising a mutation at bases 139 and 811 of the coding sequence of the wild-type pobB gene shown in SEQ ID NO. 1.
According to the present invention, the mutation refers to a change in the base/nucleotide at the site, and the mutation method may be at least one selected from the group consisting of mutagenesis, PCR site-directed mutagenesis, and/or homologous recombination.
According to the invention, the mutation is that both the 139 th base and the 811 th base in SEQ ID NO.1 are mutated from guanine (G) to adenine (A); specifically, the mutated polynucleotide sequence comprises a polynucleotide sequence shown as SEQ ID NO. 2.
In a second aspect of the invention, there is provided a recombinant protein encoded by a polynucleotide sequence as described above.
The recombinant protein comprises an amino acid sequence shown as SEQ ID NO. 4.
In a third aspect of the invention, there is provided a recombinant vector comprising the polynucleotide sequence or recombinant protein described above.
The recombinant vector is constructed by introducing the polynucleotide sequence into a plasmid; as one embodiment, the plasmid is the pK18 plasmid. Specifically, the polynucleotide sequence and the plasmid may be digested with endonuclease to form complementary cohesive ends, and the two may be ligated to construct a recombinant vector.
In a fourth aspect of the present invention, there is provided a recombinant strain comprising a nucleotide sequence encoding a pobB gene in which an open reading frame is point-mutated.
A recombinant strain according to the invention comprising a polynucleotide sequence as described in the first aspect.
As one embodiment of the present invention, it contains the nucleotide sequence shown as SEQ ID NO. 2.
As one embodiment of the present invention, it contains the amino acid sequence shown as SEQ ID NO. 4.
The recombinant strain is formed by introducing the polynucleotide sequence into a host strain for recombination; the host strain may be selected from L-lysine producing strains known in the art, for example, at least one selected from Corynebacterium glutamicum, Escherichia coli. As an embodiment of the invention, the host strain is YP097158 (preservation number: CGMCC No.12856, preservation date: 2016, 8 months and 16 days).
The recombinant strain of the present invention uses pK18 plasmid as a vector.
The recombinant strain according to the present invention may further comprise other modifications.
In the fifth aspect of the present invention, there is also provided a method for constructing a recombinant strain, comprising the steps of:
the nucleotide sequence of the open reading frame region of the wild-type pobB gene shown in SEQ ID NO.1 is modified to cause the 139 th and 811 th bases to be mutated, and the recombinant strain containing the mutant pobB coding gene is obtained.
According to the construction method of the invention, the modification comprises at least one of mutagenesis, PCR site-directed mutagenesis, homologous recombination and the like.
According to the construction method of the invention, the mutation is that the 139 th base and the 811 th base in SEQ ID NO.1 are mutated from guanine (G) to adenine (A); specifically, the mutated polynucleotide sequence is shown in SEQ ID NO. 2.
Further, the construction method comprises the following steps:
(1) transforming the nucleotide sequence of the open reading frame region of the wild-type pobB gene shown as SEQ ID NO.1 to mutate the 139 th and 811 th bases of the wild-type pobB gene to obtain a mutant pobB gene open reading frame region polynucleotide sequence;
(2) connecting the mutated polynucleotide sequence with a plasmid to construct a recombinant vector;
(3) introducing the recombinant vector into a host strain to obtain the recombinant strain containing the mutated polynucleotide sequence.
According to the construction method of the present invention, the step (1) includes: constructing a point-mutated pobB gene coding region, namely synthesizing three pairs of primers for amplifying a pobB gene coding region fragment according to a Corynebacterium glutamicum ATCC13032 genome sequence, introducing point mutation in a wild-type pobB gene coding region (SEQ ID NO:1) by a PCR (polymerase chain reaction) fixed-point mutation method to obtain a point-mutated pobB gene coding region nucleotide sequence (SEQ ID NO:2) which is marked as pobB(G139A,G811A)。
In one embodiment of the present invention, in the step (1), the primers are:
P1:5'CCGGAATTCTGCGAGAACTGTTCCGACAC 3'(EcoR I)
P2:5'CGTTTCCGCTCCACGGTCACCGAACCAATG 3'
P3:5'CATTGGTTCGGTGACCGTGGAGCGGAAACG 3'
P4:5'CGTCCGAGCAAGCATCCTGGAACAAGGCAC 3'
P5:5'GTGCCTTGTTCCAGGATGCTTGCTCGGACG 3'
P6:5'CCCAAGCTTTCACAGTAGCTTAAACCAAT 3'(Hind III)；
in one embodiment of the present invention, the step (1) comprises: the Corynebacterium glutamicum ATCC13032 is taken as a template, and primers P1 and P2, P3 and P4, P5 and P6 are respectively used for PCR amplification to obtain three DNA fragments with the separated size of 450bp, 700bp and 430bp containing the coding region of the pobB gene. Separating and purifying the three DNA fragments by agarose gel electrophoresis, and performing Overlap PCR amplification (Overlap PCR) by using the three DNA fragments as templates and using P1 and P6 as primers to obtain pobB(G139A,G811A)。
In one embodiment of the invention, the PCR amplification is performed as follows: denaturation at 94 ℃ for 30s, annealing at 52 ℃ for 30s, and extension at 72 ℃ for 30s (30 cycles).
In one embodiment of the invention, the overlapping PCR amplification is performed as follows: denaturation at 94 ℃ for 30s, annealing at 52 ℃ for 30s, and extension at 72 ℃ for 60s (30 cycles).
According to the construction method of the present invention, the step (2) comprises construction of a recombinant vector, i.e., agarose gelGel electrophoresis separation of purified pobB(G139A,G811A)And pK18 plasmid, which are respectively subjected to double digestion by restriction enzymes (such as EcoR I/Hind III), separated and purified by agarose gel electrophoresis, and then connected by DNA ligase to obtain a recombinant vector pK18-pobB(G139A ,G811A)。
According to the construction method of the present invention, the step (3) comprises constructing a recombinant strain by introducing a recombinant vector pK18-pobB(G139A,G811A)Introducing Corynebacterium glutamicum to obtain recombinant strain.
In one embodiment of the invention, the recombinant vector has a kanamycin resistance marker.
In one embodiment of the present invention, the introduction of the step (3) is an electrical conversion method; illustratively, in the step (3), the recombinant vector is electrically transformed into the strain YP 097158.
In a sixth aspect of the present invention, the present invention also provides a recombinant strain obtained by the construction method described above. Furthermore, the construction method according to the fifth aspect of the present invention can be used for constructing a recombinant strain according to the fourth aspect.
In a seventh aspect of the invention, there is provided the use of the polynucleotide sequence, recombinant vector, recombinant strain as described above in the preparation of L-lysine.
The application of the recombinant strain in the preparation of L-lysine comprises the step of fermenting the recombinant strain to prepare the L-lysine.
Advantageous effects
The invention introduces point mutation into the pobB gene coding sequence in wild corynebacterium glutamicum to obtain a recombinant strain, and compared with the non-mutated wild strain, the obtained strain is favorable for producing high-concentration L-lysine, has good strain stability, and can further reduce the production cost when being used as an L-lysine production strain.
Drawings
FIG. 1 shows pK18-pobB(G139A,G811A)And (3) plasmid mapping.
Detailed Description
The present invention will be described in further detail with reference to the following drawings and examples. However, those skilled in the art will appreciate that the scope of the present invention is not limited to the following examples. In light of the present disclosure, those skilled in the art will recognize that many variations and modifications may be made to the embodiments described above without departing from the spirit and scope of the present invention.
Example 1 construction of a transformation vector pK18-pobB (G139A, G811A) for the coding region of the pobB Gene comprising a Point mutation
Three pairs of primers for amplifying the fragments of the coding region of the pobB gene were synthesized based on the genomic sequence of Corynebacterium glutamicum ATCC13032 published by NCBI, and point mutations were introduced into the coding region of the pobB gene (SEQ ID No.1) in the background of strain YP097158 (accession No. CGMCC No.12856, accession No. 2016, 16/2016, Collection, institute of microbiology, national institute of sciences, Ministry of China, Ministry of microbiology, Ministry of North and Ministry of North, Ministry of south China, Ministry of Japan, Ministry of microbiology, Ministry of Japan, Ministry of microorganisms, and Ministry of. The primers were designed as follows (synthesized by Shanghai Invitrogen corporation):
P1:5'CCGGAATTCTGCGAGAACTGTTCCGACAC 3'(Ecor I)(SEQ ID NO.5)
P2:5'CGTTTCCGCTCCACGGTCACCGAACCAATG 3'(SEQ ID NO.6)
P3:5'CATTGGTTCGGTGACCGTGGAGCGGAAACG 3'(SEQ ID NO.7)
P4:5'CGTCCGAGCAAGCATCCTGGAACAAGGCAC 3'(SEQ ID NO.8)
P5:5'GTGCCTTGTTCCAGGATGCTTGCTCGGACG 3'(SEQ ID NO.9)
P6:5'CCCAAGCTTTCACAGTAGCTTAAACCAAT 3'(Hind III)(SEQ ID NO.10)
the construction method comprises the following steps: using corynebacterium glutamicum ATCC13032 as a template, and primers P1 and P2, P3 and P4, P5 and P6 respectively, performing PCR amplification, wherein a PCR system comprises the following components: 10 XEx Taq Buffer 5. mu.L, dNTP mix (2.5 mM each) 4. mu.L, MgCl2(25mM) 4. mu.L, primers (10pM) 2. mu.L each, Ex Taq (5U/. mu.L) 0.25. mu.L in total volume 50. mu.L, the PCR amplification was performed as follows: pre-denaturation at 94 ℃ for 5min, (denaturation at 94 ℃ for 30s, annealing at 52 ℃ for 30s, extension at 72 ℃ for 30s, 30 cycles), and over-extension at 72 ℃ for 10min to obtain three DNA fragments (pobB-Up and pobB-Down) with the sizes of 450bp, 700bp and 430bp respectively and containing the coding region of the pobB gene.
Separating and purifying the three DNA fragments by agarose gel electrophoresis, and amplifying a fragment with the length of about 1420bp by using the three DNA fragments as templates and P1 and P6 as primers through an Overlap PCR (polymerase chain reaction) system: 10 XEx TaqBuffer 5. mu.L, dNTP mix (2.5 mM each) 4. mu.L, MgCl24 μ L (25mM), 2 μ L each of primers (10pM), 0.25 μ L of Ex Taq (5U/. mu.L) in total volume of 50 μ L, and the PCR amplification was performed as follows: pre-denaturation at 94 ℃ for 5min, (denaturation at 94 ℃ for 30s, annealing at 52 ℃ for 30s, extension at 72 ℃ for 90s, 30 cycles), and over-extension at 72 ℃ for 10min to obtain mutant DNA fragment pobB(G139A ,G811A). This DNA fragment resulted in the mutation of guanine (G) to adenine (A) at both positions 139 and 811 of the coding region of YP097158pobB gene, and finally in the mutation of glycine (G) to serine (S) at position 47 and alanine (A) to threonine (T) at position 271 of the encoded protein.
Separating the purified pobB by agarose gel electrophoresis(G139A,G811A)And pK18mobsacB plasmid (purchased from Addgene) were separately digested with EcoR I/Hind III, separated and purified by agarose gel electrophoresis, and ligated with DNA ligase to obtain vector pK18-pobB(G139A,G811A)The plasmid contains a kanamycin resistance marker. And the vector pK18-pobB(G139A,G811A)Sending to a sequencer for sequencing identification, and obtaining the result shown in figure 1 and SEQ ID No.15, and carrying out the pK18-pobB on the vector containing the correct point mutation (G-A)(G139A,G811A)And (5) storing for later use.
Example 2 construction of pobB comprising Point mutations(G139A,G811A)Of (4) an engineered strain
The construction method comprises the following steps: substitution of the allele for the vector pK18-pobB(G139A,G811A)Transformed into L-lysine-producing strain YP097158 (see the construction method of engineering strain in WO2014121669A 1; and sequencing to confirm the staining of the strainThe body retains the wild type pobB gene coding region), and the single colony generated by culture is respectively identified by a primer P1 and a universal primer M13F, so that the strain which can amplify a band with the size of about 1600bp is a positive strain. The positive strain was cultured on a medium containing 15% sucrose, and the single colonies produced by the culture were cultured on a medium containing kanamycin and a medium not containing kanamycin, respectively, and grown on a medium not containing kanamycin, while the strains that did not grow on a medium containing kanamycin were further subjected to PCR identification using primers P7 and P8, P9 and P10 (synthesized by Shanghai Invitrogen Co.):
P7:5'AGGTGTAGCTATCGAGCAAG 3'(SEQ ID NO.11)
P8:5'AGCGCTACTACCTGCAGTGC 3'(SEQ ID NO.12)
P9:5'TGCTGCGGGTAGATCGCAAC 3'(SEQ ID NO.13)
P10:5'GCGCAGGACCAGCAGGAC 3'(SEQ ID NO.14)
the PCR amplification product was subjected to sscp electrophoresis (using vector pK 18-pobB) after denaturation at high temperature and ice-bath(G139A ,G811A)The amplified fragment is a positive control, the YP097158 amplified fragment is a negative control, and water is used as a blank control). due to the different fragment structures and different electrophoresis positions, the strain with the fragment electrophoresis position inconsistent with the negative control fragment position and consistent with the positive control fragment position is a strain with successful allelic replacement. PCR amplifying the target fragment of the positive strain again by using primers P7 and P10, connecting the amplified target fragment to a PMD19-T vector for sequencing, verifying the allelic replacement success of the strain by sequence alignment of a mutated base sequence, and carrying out the amplification of the target fragment of the positive strain by using the primers P7 and P10(G139A,G811A)The point-mutated strain is named YPL-4-012
EXAMPLE 3L-lysine fermentation experiment
Example 2 the constructed strain YPL-4-012 and original strain YP097158 were subjected to fermentation experiments in a BLBIO-5GC-4-H model fermenter (purchased from Bailan Biotech Co., Ltd., Shanghai) with the media shown in Table 1 and the control procedures shown in Table 2. Each strain was replicated three times, and the results are shown in Table 3.
TABLE 1 fermentation Medium formulation
Composition (I) Formulation of
Starch hydrolysis sugar 30g/L
Ammonium sulfate 12g/L
Magnesium sulfate 0.87g/L
Molasses for health protection 20g/L
Acidified corn steep liquor 3mL/L
Phosphoric acid 0.4mL/L
Potassium chloride 0.53g/L
Defoaming agent (2% foam) 4mL/L
Ferrous sulfate 120mg/L
Manganese sulfate 120mg/L
Nicotinamide 42mg/L
Calcium pantothenate 6.3mg/L
Vitamin B1 6.3mg/L
Solution of copper or zinc salt 0.6g/L
Biotin 0.88mg/L
TABLE 2 fermentation control Process
TABLE 3 results of L-lysine fermentation experiments
As a result, as shown in Table 3, the coding region of the pobB gene was point-mutated in Corynebacterium glutamicum(G139A ,G811A)And contributes to the improvement of the yield of the L-lysine.
Sequence listing
<110> Nemeng Guyi products Biotechnology Ltd
<120> recombinant strain for high yield of L-lysine, construction method and application thereof
<130> CPCN19110495
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1188
<212> DNA
<213> Corynebacterium glutamicum
<400> 1
atgaaccacg taccagtggc aattattggc gcaggaccag caggactaac cctcgcccac 60
ctcctccacc ttcaaggtgt ggaatcaatc gtctttgaat cccgcacccg caaggacgtc 120
gaagaaaccg tccgagcagg catcctggaa caaggcaccc tgaatctgat gcgcgaaacc 180
ggagtcggcg cacgcatgga agcagaagcc gatcacgatg aagcaatcga catctccatc 240
aacaatgagc gcacccgcat tccgctgacc gaactcaccg gccacaaggt tgcgatctac 300
ccgcagcacg aatacctcaa agatttcatt gccaagcgca tcgaagatgg cggcgaactc 360
cttttcacca ccactgttga ttccgtagaa aactacgaag gcgacctcgc caaggtgacc 420
tacaccgaag ccgatggttc ctccaccacc atcaccgccg actacgtcat cgcagctgac 480
ggctccaact ccccttaccg caagctgatc accgaagacg gtggcgtgcg cgcccgccat 540
gaataccctt acgcatggtt cggcattttg gtggaagcac caaaaaccca aaaggaactc 600
atctacgcaa cccaccctga gggctttgcg ctgatctcca cccgtaccga tgaaatccag 660
cgctactacc tgcagtgcaa ccctgacgac accccagaca tgtggcccga tgaccgcatt 720
tgggaacagc tgcacctgcg tgcggactcc cctggcatca ccgtgtctga agggcgcatc 780
tttgacaagg ccgtgctgcg tttctgctcc gcggtcaccg aaccaatgca aaagggacgc 840
ctcttccttg ctggcgatgc tgcacacacc gtgccgccaa ccggagctaa gggcctcaac 900
ttggctgttg ccgatgtctc agtactcgcg ccagcactgg ttcgtgccct gaagaagaag 960
gacaccggct tgctcgatag ctacacctcc ctggcagtcc cccgcatctg gaaagcacag 1020
cacttctcct actggatgag ctccatgctc cacgcagtac ccggcgaaga tcactttgcc 1080
acccagcgcc gattcgctga attgcgctcc gtcctagaat cccaatccgg ccaacgctac 1140
ctcgcagagc agtacgttgg gcgcgaccta ccacgcttcg aggtataa 1188
<210> 2
<211> 1188
<212> DNA
<213> Artificial sequence
<400> 2
atgaaccacg taccagtggc aattattggc gcaggaccag caggactaac cctcgcccac 60
ctcctccacc ttcaaggtgt ggaatcaatc gtctttgaat cccgcacccg caaggacgtc 120
gaagaaaccg tccgagcaag catcctggaa caaggcaccc tgaatctgat gcgcgaaacc 180
ggagtcggcg cacgcatgga agcagaagcc gatcacgatg aagcaatcga catctccatc 240
aacaatgagc gcacccgcat tccgctgacc gaactcaccg gccacaaggt tgcgatctac 300
ccgcagcacg aatacctcaa agatttcatt gccaagcgca tcgaagatgg cggcgaactc 360
cttttcacca ccactgttga ttccgtagaa aactacgaag gcgacctcgc caaggtgacc 420
tacaccgaag ccgatggttc ctccaccacc atcaccgccg actacgtcat cgcagctgac 480
ggctccaact ccccttaccg caagctgatc accgaagacg gtggcgtgcg cgcccgccat 540
gaataccctt acgcatggtt cggcattttg gtggaagcac caaaaaccca aaaggaactc 600
atctacgcaa cccaccctga gggctttgcg ctgatctcca cccgtaccga tgaaatccag 660
cgctactacc tgcagtgcaa ccctgacgac accccagaca tgtggcccga tgaccgcatt 720
tgggaacagc tgcacctgcg tgcggactcc cctggcatca ccgtgtctga agggcgcatc 780
tttgacaagg ccgtgctgcg tttctgctcc acggtcaccg aaccaatgca aaagggacgc 840
ctcttccttg ctggcgatgc tgcacacacc gtgccgccaa ccggagctaa gggcctcaac 900
ttggctgttg ccgatgtctc agtactcgcg ccagcactgg ttcgtgccct gaagaagaag 960
gacaccggct tgctcgatag ctacacctcc ctggcagtcc cccgcatctg gaaagcacag 1020
cacttctcct actggatgag ctccatgctc cacgcagtac ccggcgaaga tcactttgcc 1080
acccagcgcc gattcgctga attgcgctcc gtcctagaat cccaatccgg ccaacgctac 1140
ctcgcagagc agtacgttgg gcgcgaccta ccacgcttcg aggtataa 1188
<210> 3
<211> 395
<212> PRT
<213> Corynebacterium glutamicum
<400> 3
Met Asn His Val Pro Val Ala Ile Ile Gly Ala Gly Pro Ala Gly Leu
1 5 10 15
Thr Leu Ala His Leu Leu His Leu Gln Gly Val Glu Ser Ile Val Phe
20 25 30
Glu Ser Arg Thr Arg Lys Asp Val Glu Glu Thr Val Arg Ala Gly Ile
35 40 45
Leu Glu Gln Gly Thr Leu Asn Leu Met Arg Glu Thr Gly Val Gly Ala
50 55 60
Arg Met Glu Ala Glu Ala Asp His Asp Glu Ala Ile Asp Ile Ser Ile
65 70 75 80
Asn Asn Glu Arg Thr Arg Ile Pro Leu Thr Glu Leu Thr Gly His Lys
85 90 95
Val Ala Ile Tyr Pro Gln His Glu Tyr Leu Lys Asp Phe Ile Ala Lys
100 105 110
Arg Ile Glu Asp Gly Gly Glu Leu Leu Phe Thr Thr Thr Val Asp Ser
115 120 125
Val Glu Asn Tyr Glu Gly Asp Leu Ala Lys Val Thr Tyr Thr Glu Ala
130 135 140
Asp Gly Ser Ser Thr Thr Ile Thr Ala Asp Tyr Val Ile Ala Ala Asp
145 150 155 160
Gly Ser Asn Ser Pro Tyr Arg Lys Leu Ile Thr Glu Asp Gly Gly Val
165 170 175
Arg Ala Arg His Glu Tyr Pro Tyr Ala Trp Phe Gly Ile Leu Val Glu
180 185 190
Ala Pro Lys Thr Gln Lys Glu Leu Ile Tyr Ala Thr His Pro Glu Gly
195 200 205
Phe Ala Leu Ile Ser Thr Arg Thr Asp Glu Ile Gln Arg Tyr Tyr Leu
210 215 220
Gln Cys Asn Pro Asp Asp Thr Pro Asp Met Trp Pro Asp Asp Arg Ile
225 230 235 240
Trp Glu Gln Leu His Leu Arg Ala Asp Ser Pro Gly Ile Thr Val Ser
245 250 255
Glu Gly Arg Ile Phe Asp Lys Ala Val Leu Arg Phe Cys Ser Ala Val
260 265 270
Thr Glu Pro Met Gln Lys Gly Arg Leu Phe Leu Ala Gly Asp Ala Ala
275 280 285
His Thr Val Pro Pro Thr Gly Ala Lys Gly Leu Asn Leu Ala Val Ala
290 295 300
Asp Val Ser Val Leu Ala Pro Ala Leu Val Arg Ala Leu Lys Lys Lys
305 310 315 320
Asp Thr Gly Leu Leu Asp Ser Tyr Thr Ser Leu Ala Val Pro Arg Ile
325 330 335
Trp Lys Ala Gln His Phe Ser Tyr Trp Met Ser Ser Met Leu His Ala
340 345 350
Val Pro Gly Glu Asp His Phe Ala Thr Gln Arg Arg Phe Ala Glu Leu
355 360 365
Arg Ser Val Leu Glu Ser Gln Ser Gly Gln Arg Tyr Leu Ala Glu Gln
370 375 380
Tyr Val Gly Arg Asp Leu Pro Arg Phe Glu Val
385 390 395
<210> 4
<211> 395
<212> PRT
<213> Artificial sequence
<400> 4
Met Asn His Val Pro Val Ala Ile Ile Gly Ala Gly Pro Ala Gly Leu
1 5 10 15
Thr Leu Ala His Leu Leu His Leu Gln Gly Val Glu Ser Ile Val Phe
20 25 30
Glu Ser Arg Thr Arg Lys Asp Val Glu Glu Thr Val Arg Ala Ser Ile
35 40 45
Leu Glu Gln Gly Thr Leu Asn Leu Met Arg Glu Thr Gly Val Gly Ala
50 55 60
Arg Met Glu Ala Glu Ala Asp His Asp Glu Ala Ile Asp Ile Ser Ile
65 70 75 80
Asn Asn Glu Arg Thr Arg Ile Pro Leu Thr Glu Leu Thr Gly His Lys
85 90 95
Val Ala Ile Tyr Pro Gln His Glu Tyr Leu Lys Asp Phe Ile Ala Lys
100 105 110
Arg Ile Glu Asp Gly Gly Glu Leu Leu Phe Thr Thr Thr Val Asp Ser
115 120 125
Val Glu Asn Tyr Glu Gly Asp Leu Ala Lys Val Thr Tyr Thr Glu Ala
130 135 140
Asp Gly Ser Ser Thr Thr Ile Thr Ala Asp Tyr Val Ile Ala Ala Asp
145 150 155 160
Gly Ser Asn Ser Pro Tyr Arg Lys Leu Ile Thr Glu Asp Gly Gly Val
165 170 175
Arg Ala Arg His Glu Tyr Pro Tyr Ala Trp Phe Gly Ile Leu Val Glu
180 185 190
Ala Pro Lys Thr Gln Lys Glu Leu Ile Tyr Ala Thr His Pro Glu Gly
195 200 205
Phe Ala Leu Ile Ser Thr Arg Thr Asp Glu Ile Gln Arg Tyr Tyr Leu
210 215 220
Gln Cys Asn Pro Asp Asp Thr Pro Asp Met Trp Pro Asp Asp Arg Ile
225 230 235 240
Trp Glu Gln Leu His Leu Arg Ala Asp Ser Pro Gly Ile Thr Val Ser
245 250 255
Glu Gly Arg Ile Phe Asp Lys Ala Val Leu Arg Phe Cys Ser Thr Val
260 265 270
Thr Glu Pro Met Gln Lys Gly Arg Leu Phe Leu Ala Gly Asp Ala Ala
275 280 285
His Thr Val Pro Pro Thr Gly Ala Lys Gly Leu Asn Leu Ala Val Ala
290 295 300
Asp Val Ser Val Leu Ala Pro Ala Leu Val Arg Ala Leu Lys Lys Lys
305 310 315 320
Asp Thr Gly Leu Leu Asp Ser Tyr Thr Ser Leu Ala Val Pro Arg Ile
325 330 335
Trp Lys Ala Gln His Phe Ser Tyr Trp Met Ser Ser Met Leu His Ala
340 345 350
Val Pro Gly Glu Asp His Phe Ala Thr Gln Arg Arg Phe Ala Glu Leu
355 360 365
Arg Ser Val Leu Glu Ser Gln Ser Gly Gln Arg Tyr Leu Ala Glu Gln
370 375 380
Tyr Val Gly Arg Asp Leu Pro Arg Phe Glu Val
385 390 395
<210> 5
<211> 29
<212> DNA
<213> Artificial sequence
<400> 5
ccggaattct gcgagaactg ttccgacac 29
<210> 6
<211> 30
<212> DNA
<213> Artificial sequence
<400> 6
cgtttccgct ccacggtcac cgaaccaatg 30
<210> 7
<211> 30
<212> DNA
<213> Artificial sequence
<400> 7
cattggttcg gtgaccgtgg agcggaaacg 30
<210> 8
<211> 30
<212> DNA
<213> Artificial sequence
<400> 8
cgtccgagca agcatcctgg aacaaggcac 30
<210> 9
<211> 30
<212> DNA
<213> Artificial sequence
<400> 9
gtgccttgtt ccaggatgct tgctcggacg 30
<210> 10
<211> 29
<212> DNA
<213> Artificial sequence
<400> 10
cccaagcttt cacagtagct taaaccaat 29
<210> 11
<211> 20
<212> DNA
<213> Artificial sequence
<400> 11
aggtgtagct atcgagcaag 20
<210> 12
<211> 20
<212> DNA
<213> Artificial sequence
<400> 12
agcgctacta cctgcagtgc 20
<210> 13
<211> 20
<212> DNA
<213> Artificial sequence
<400> 13
tgctgcgggt agatcgcaac 20
<210> 14
<211> 18
<212> DNA
<213> Artificial sequence
<400> 14
gcgcaggacc agcaggac 18
<210> 15
<211> 930
<212> DNA
<213> Artificial sequence
<400> 15
gcaggaccag caggactaac cctcgcccac ctcctccacc ttcaaggtgt ggaatcaatc 60
gtctttgaat cccgcacccg caaggacgtc gaagaaaccg tccgagcaag catcctggaa 120
caaggcaccc tgaatctgat gcgcgaaacc ggagtcggcg cacgcatgga agcagaagcc 180
gatcacgatg aagcaatcga catctccatc aacaatgagc gcacccgcat tccgctgacc 240
gaactcaccg gccacaaggt tgcgatctac ccgcagcacg aatacctcaa agatttcatt 300
gccaagcgca tcgaagatgg cggcgaactc cttttcacca ccactgttga ttccgtagaa 360
aactacgaag gcgacctcgc caaggtgacc tacaccgaag ccgatggttc ctccaccacc 420
atcaccgccg actacgtcat cgcagctgac ggctccaact ccccttaccg caagctgatc 480
accgaagacg gtggcgtgcg cgcccgccat gaataccctt acgcatggtt cggcattttg 540
gtggaagcac caaaaaccca aaaggaactc atctacgcaa cccaccctga gggctttgcg 600
ctgatctcca cccgtaccga tgaaatccag cgctactacc tgcagtgcaa ccctgacgac 660
accccagaca tgtggcccga tgaccgcatt tgggaacagc tgcacctgcg tgcggactcc 720
cctggcatca ccgtgtctga agggcgcatc tttgacaagg ccgtgctgcg tttctgctcc 780
acggtcaccg aaccaatgca aaagggacgc ctcttccttg ctggcgatgc tgcacacacc 840
gtgccgccaa ccggagctaa gggcctcaac ttggctgttg ccgatgtctc agtactcgcg 900
ccagcactgg ttcgtgccct gaagaagaag 930

Claims (10)

1. A polynucleotide sequence, which is characterized by comprising a polynucleotide sequence formed by mutation of 139 th and 811 th bases of a coding sequence of a wild-type pobB gene shown in SEQ ID NO. 1;
preferably, the mutation is that both 139 th and 811 th bases in SEQ ID NO.1 are mutated from guanine (G) to adenine (A), and the mutated polynucleotide sequence comprises a polynucleotide sequence shown in SEQ ID NO. 2.
2. A recombinant protein encoded by the polynucleotide sequence of claim 1.
3. The recombinant protein according to claim 2, wherein the amino acid sequence of said recombinant protein comprises the amino acid sequence shown in SEQ ID NO. 4.
4. A recombinant vector comprising the polynucleotide sequence of claim 1.
5. The recombinant vector according to claim 4, which is constructed by introducing the polynucleotide sequence into a plasmid.
6. A recombinant strain comprising a nucleotide sequence encoding a pobB gene with a point mutation in the open reading frame;
preferably, the recombinant strain contains a polynucleotide sequence according to claim 1.
7. The method of constructing a recombinant strain according to claim 6, comprising the steps of:
(1) transforming a nucleotide sequence shown as SEQ ID NO.1 to make 139 th and 811 th bases of the nucleotide sequence mutated to obtain a mutated open reading frame region polynucleotide sequence of the pobB gene;
(2) connecting the mutated polynucleotide sequence with a plasmid to construct a recombinant vector;
(3) and (3) introducing the recombinant vector into a host strain to obtain the recombinant strain.
8. The construction process according to claim 7, wherein the host strain is Corynebacterium glutamicum or Escherichia coli, preferably Corynebacterium glutamicum CGMCC No. 12856;
preferably, the step (1) includes: carrying out PCR amplification by using Corynebacterium glutamicum ATCC13032 as a template and primers P1 and P2, P3 and P4, P5 and P6 respectively to obtain three DNA fragments; after the three DNA fragments are purified, the three DNA fragments are taken as a template toP1 and P6 are primers, and the pobB is obtained by overlapping PCR amplification(G139A,G811A)Preferably, the sequences of the primers are respectively: the primer P1 is shown as SEQ ID NO.5, the primer P2 is shown as SEQ ID NO.6, the primer P3 is shown as SEQ ID NO.7, the primer P4 is shown as SEQ ID NO.8, the primer P5 is shown as SEQ ID NO.9, and the primer P6 is shown as SEQ ID NO. 10;
preferably, the step (2) comprises separating and purifying the separated and purified pobB(G139A,G811A)And plasmids, which are double-digested with restriction enzymes (such as EcoR I/Hind III) respectively, and ligated by DNA ligase to obtain the recombinant vector pK18-pobB(G139A ,G811A)；
Preferably, the step (3) comprises electrically transforming the recombinant vector into a host strain.
9. Use of a polynucleotide sequence according to claims 1-6 or a recombinant protein or a recombinant vector or a recombinant strain for the production of L-lysine.
10. The use according to claim 9, wherein the recombinant strain is used for the fermentative preparation of L-lysine.
CN201910926308.1A 2019-09-27 2019-09-27 Recombinant strain for high yield of L-lysine and construction method and application thereof Active CN110607313B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910926308.1A CN110607313B (en) 2019-09-27 2019-09-27 Recombinant strain for high yield of L-lysine and construction method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910926308.1A CN110607313B (en) 2019-09-27 2019-09-27 Recombinant strain for high yield of L-lysine and construction method and application thereof

Publications (2)

Publication Number Publication Date
CN110607313A true CN110607313A (en) 2019-12-24
CN110607313B CN110607313B (en) 2021-06-22

Family

ID=68893856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910926308.1A Active CN110607313B (en) 2019-09-27 2019-09-27 Recombinant strain for high yield of L-lysine and construction method and application thereof

Country Status (1)

Country Link
CN (1) CN110607313B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111197021A (en) * 2020-01-13 2020-05-26 江南大学 Recombinant corynebacterium glutamicum with improved L-lysine yield and construction method thereof
CN111850010A (en) * 2020-06-08 2020-10-30 黑龙江伊品生物科技有限公司 dapB gene modified recombinant strain and construction method and application thereof
CN111979165A (en) * 2020-08-07 2020-11-24 黑龙江伊品生物科技有限公司 Recombinant strain for producing L-lysine and construction method and application thereof
CN112646767A (en) * 2020-12-30 2021-04-13 宁夏伊品生物科技股份有限公司 Strain with enhanced L-glutamic acid productivity and construction method and application thereof
CN112725253A (en) * 2020-12-30 2021-04-30 宁夏伊品生物科技股份有限公司 Recombinant strain for modifying gene BBD 29-14900 and construction method and application thereof
CN115490761A (en) * 2021-11-01 2022-12-20 中国科学院天津工业生物技术研究所 Recombinant microorganism constructed based on lysine efflux protein and method for producing lysine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103131738A (en) * 2013-02-08 2013-06-05 宁夏伊品生物科技股份有限公司 Bacteria fermenting and producing L-lysine method by using changed aconitase to regulate and control unit
CN103703137A (en) * 2012-01-27 2014-04-02 株式会社吉那里斯 Method for producing useful chemical substance from terephthalic acid potassium salt
WO2014121669A1 (en) * 2013-02-08 2014-08-14 宁夏伊品生物科技股份有限公司 L-lysine generation method by fermenting bacteria having modified aconitase gene and/or regulatory element
CN104379729A (en) * 2012-07-03 2015-02-25 株式会社吉那里斯 Useful microorganism, and method for producing desired substance
CN106367432A (en) * 2016-09-01 2017-02-01 宁夏伊品生物科技股份有限公司 Method for producing L-lysine by fermentation and modified corynebacterium lilium

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103703137A (en) * 2012-01-27 2014-04-02 株式会社吉那里斯 Method for producing useful chemical substance from terephthalic acid potassium salt
CN104379729A (en) * 2012-07-03 2015-02-25 株式会社吉那里斯 Useful microorganism, and method for producing desired substance
CN103131738A (en) * 2013-02-08 2013-06-05 宁夏伊品生物科技股份有限公司 Bacteria fermenting and producing L-lysine method by using changed aconitase to regulate and control unit
WO2014121669A1 (en) * 2013-02-08 2014-08-14 宁夏伊品生物科技股份有限公司 L-lysine generation method by fermenting bacteria having modified aconitase gene and/or regulatory element
CN106367432A (en) * 2016-09-01 2017-02-01 宁夏伊品生物科技股份有限公司 Method for producing L-lysine by fermentation and modified corynebacterium lilium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARILIZ ORTIZ-MALDONADO等: "Synergistic Interactions of Multiple Mutations on Catalysis during the Hydroxylation Reaction of p-Hydroxybenzoate Hydroxylase: Studies of the Lys297Met, Asn300Asp, and Tyr385Phe Mutants Reconstituted with 8-Cl-Flavin", 《BIOCHEMISTRY》 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111197021A (en) * 2020-01-13 2020-05-26 江南大学 Recombinant corynebacterium glutamicum with improved L-lysine yield and construction method thereof
CN111197021B (en) * 2020-01-13 2021-09-21 江南大学 Recombinant corynebacterium glutamicum with improved L-lysine yield and construction method thereof
CN111850010A (en) * 2020-06-08 2020-10-30 黑龙江伊品生物科技有限公司 dapB gene modified recombinant strain and construction method and application thereof
CN111979165A (en) * 2020-08-07 2020-11-24 黑龙江伊品生物科技有限公司 Recombinant strain for producing L-lysine and construction method and application thereof
CN111979165B (en) * 2020-08-07 2021-05-07 黑龙江伊品生物科技有限公司 Recombinant strain for producing L-lysine and construction method and application thereof
CN112646767A (en) * 2020-12-30 2021-04-13 宁夏伊品生物科技股份有限公司 Strain with enhanced L-glutamic acid productivity and construction method and application thereof
CN112725253A (en) * 2020-12-30 2021-04-30 宁夏伊品生物科技股份有限公司 Recombinant strain for modifying gene BBD 29-14900 and construction method and application thereof
CN115490761A (en) * 2021-11-01 2022-12-20 中国科学院天津工业生物技术研究所 Recombinant microorganism constructed based on lysine efflux protein and method for producing lysine
CN115490761B (en) * 2021-11-01 2023-06-09 中国科学院天津工业生物技术研究所 Recombinant microorganism constructed based on lysine efflux protein and method for producing lysine

Also Published As

Publication number Publication date
CN110607313B (en) 2021-06-22

Similar Documents

Publication Publication Date Title
CN110607313B (en) Recombinant strain for high yield of L-lysine and construction method and application thereof
CN111979164B (en) Recombinant strain for producing L-lysine and construction method and application thereof
CN111979165B (en) Recombinant strain for producing L-lysine and construction method and application thereof
CN111850010B (en) dapB gene modified recombinant strain and construction method and application thereof
CN113683667B (en) Engineering bacterium obtained by modification of YH66-RS10865 gene and application thereof in valine preparation
CN111961635B (en) Recombinant strain for producing L-lysine and construction method and application thereof
CN111471693B (en) Corynebacterium glutamicum for producing lysine and construction method and application thereof
CN110846333B (en) Recombinant strain modified by deoB gene and construction method and application thereof
CN110592109B (en) Recombinant strain modified by spoT gene and construction method and application thereof
CN110846312B (en) Promoter nucleic acid sequence of sdaA gene, recombinant strain containing nucleic acid sequence and application of recombinant strain
CN110592084B (en) Recombinant strain transformed by rhtA gene promoter, construction method and application thereof
CN112646767A (en) Strain with enhanced L-glutamic acid productivity and construction method and application thereof
CN114181288B (en) Process for producing L-valine, gene used therefor and protein encoded by the gene
CN114835783A (en) NCgl2747 gene mutant and application thereof in preparation of L-lysine
CN112538491B (en) YH66_08550 gene-based recombinant strain for producing L-isoleucine as well as construction method and application thereof
CN110804617B (en) KdtA gene modified recombinant strain and construction method and application thereof
CN114409751A (en) YH 66-04470 gene mutation recombinant bacterium and application thereof in preparation of arginine
CN114540399A (en) Method for preparing L-valine and gene mutant and biological material used by same
CN114349831A (en) aspA gene mutant, recombinant bacterium and method for preparing L-valine
CN110564742B (en) Recombinant strain modified by yebN gene and construction method and application thereof
CN114315998B (en) CEY17_RS00300 gene mutant and application thereof in preparation of L-valine
CN114507273B (en) YH66_07020 protein and application of related biological material thereof in improving arginine yield
CN112266891B (en) Recombinant strain for producing L-amino acid and construction method and application thereof
CN114277069B (en) Method for preparing L-valine and biological material used by same
CN114369559B (en) Recombinant strain for producing L-amino acid and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210928

Address after: Yanghe Industrial Park, Yongning County, Yinchuan City, Ningxia Hui Autonomous Region

Patentee after: NINGXIA EPPEN BIOTECH Co.,Ltd.

Address before: 024000 office building of Management Committee of resource based city economic transformation and Development Experimental Zone in Chifeng City, Inner Mongolia Autonomous Region

Patentee before: INNER MONGOLIA EPPEN BIOTECH Co.,Ltd.

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A recombinant strain with high yield of L-lysine and its construction method and Application

Effective date of registration: 20220323

Granted publication date: 20210622

Pledgee: Yongning County Branch of China Agricultural Development Bank

Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.

Registration number: Y2022640000002

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230315

Granted publication date: 20210622

Pledgee: Yongning County Branch of China Agricultural Development Bank

Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.|INNER MONGOLIA EPPEN BIOTECH Co.,Ltd.|Heilongjiang Yipin Biotechnology Co.,Ltd.

Registration number: Y2022640000002

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A recombinant strain with high production of L-lysine and its construction method and application

Granted publication date: 20210622

Pledgee: Yongning County Branch of China Agricultural Development Bank

Pledgor: NINGXIA EPPEN BIOTECH Co.,Ltd.|INNER MONGOLIA EPPEN BIOTECH Co.,Ltd.|Heilongjiang Yipin Biotechnology Co.,Ltd.

Registration number: Y2024640000005

PE01 Entry into force of the registration of the contract for pledge of patent right